Your browser doesn't support javascript.
loading
Efficacy and safety of rituximab in systemic sclerosis: French retrospective study and literature review.
Thiebaut, Mathilde; Launay, David; Rivière, Sébastien; Mahévas, Thibault; Bellakhal, Syrine; Hachulla, Eric; Fain, Olivier; Mekinian, Arsène.
Affiliation
  • Thiebaut M; Department of Internal Medicine, Inflammation-Immunopathology-Biotherapy Department (DHU i2B), Assistance Publique - Hôpitaux de Paris, Hôpital Saint-Antoine, 184, rue du Faubourg Saint-Antoine, 75012 Paris, France; Sorbonne Universités, UMPC University Paris 06, INSERM U938, Centre de Recherche Sai
  • Launay D; Univ. Lille, INSERM U995 - LIRIC - Lille Inflammation Research International Center, F-59000 Lille, France; INSERM, U995, F-59000 Lille, France; CHU Lille, Département de Médecine Interne et Immunologie Clinique, F-59000 Lille, France; Centre National de Référence Maladies Systémiques et Auto-immune
  • Rivière S; Department of Internal Medicine, Inflammation-Immunopathology-Biotherapy Department (DHU i2B), Assistance Publique - Hôpitaux de Paris, Hôpital Saint-Antoine, 184, rue du Faubourg Saint-Antoine, 75012 Paris, France.
  • Mahévas T; Department of Internal Medicine, Inflammation-Immunopathology-Biotherapy Department (DHU i2B), Assistance Publique - Hôpitaux de Paris, Hôpital Saint-Antoine, 184, rue du Faubourg Saint-Antoine, 75012 Paris, France.
  • Bellakhal S; Service de Médecine Interne-Hôpital des Forces de Sécurité Intérieure-La Marsa-Tunisie, Université de Tunis El Manar-Faculté de médecine de Tunis, Tunisia.
  • Hachulla E; Univ. Lille, INSERM U995 - LIRIC - Lille Inflammation Research International Center, F-59000 Lille, France; INSERM, U995, F-59000 Lille, France.
  • Fain O; Department of Internal Medicine, Inflammation-Immunopathology-Biotherapy Department (DHU i2B), Assistance Publique - Hôpitaux de Paris, Hôpital Saint-Antoine, 184, rue du Faubourg Saint-Antoine, 75012 Paris, France; Sorbonne Universités, UMPC University Paris 06, INSERM U938, Centre de Recherche Sai
  • Mekinian A; Department of Internal Medicine, Inflammation-Immunopathology-Biotherapy Department (DHU i2B), Assistance Publique - Hôpitaux de Paris, Hôpital Saint-Antoine, 184, rue du Faubourg Saint-Antoine, 75012 Paris, France; Sorbonne Universités, UMPC University Paris 06, INSERM U938, Centre de Recherche Sai
Autoimmun Rev ; 17(6): 582-587, 2018 Jun.
Article in En | MEDLINE | ID: mdl-29635080
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Scleroderma, Systemic / Rituximab Type of study: Observational_studies / Risk_factors_studies / Systematic_reviews Limits: Humans Country/Region as subject: Europa Language: En Journal: Autoimmun Rev Journal subject: ALERGIA E IMUNOLOGIA Year: 2018 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Scleroderma, Systemic / Rituximab Type of study: Observational_studies / Risk_factors_studies / Systematic_reviews Limits: Humans Country/Region as subject: Europa Language: En Journal: Autoimmun Rev Journal subject: ALERGIA E IMUNOLOGIA Year: 2018 Document type: Article Country of publication: